Article Correctness Is Author's Responsibility: Study shows CRISPR effectiveness against colitis pathogen

(North Carolina State University) Research at North Carolina State University shows that the CRISPR-Cas system can be used to effectively target and eliminate specific gut bacteria, in this case Clostridioides difficile, the pathogen that causes colitis -- a chronic, degenerative disease of the colon. In a proof-of-concept study published in the journal mBio, researchers were able to show pathogen reductions in experiments conducted both on the lab bench and in mice.